Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Definitive Healthcare (DH) Interest Expenses (2020 - 2026)

Definitive Healthcare filings provide 6 years of Interest Expenses readings, the most recent being $2.9 million for Q4 2025.

  • On a quarterly basis, Interest Expenses fell 17.36% to $2.9 million in Q4 2025 year-over-year; TTM through Dec 2025 was $11.3 million, a 23.59% decrease, with the full-year FY2025 number at $11.3 million, down 23.84% from a year prior.
  • Interest Expenses hit $2.9 million in Q4 2025 for Definitive Healthcare, down from $3.0 million in the prior quarter.
  • In the past five years, Interest Expenses ranged from a high of $8.5 million in Q1 2021 to a low of $15000.0 in Q1 2022.
  • Median Interest Expenses over the past 5 years was $3.6 million (2023), compared with a mean of $3.7 million.
  • Biggest five-year swings in Interest Expenses: crashed 99.82% in 2022 and later skyrocketed 23993.33% in 2023.
  • Definitive Healthcare's Interest Expenses stood at $1.9 million in 2021, then dropped by 22.56% to $1.5 million in 2022, then skyrocketed by 162.71% to $3.9 million in 2023, then decreased by 9.93% to $3.5 million in 2024, then fell by 17.36% to $2.9 million in 2025.
  • The last three reported values for Interest Expenses were $2.9 million (Q4 2025), $3.0 million (Q3 2025), and $3.0 million (Q2 2025) per Business Quant data.